Bariatric Surgery is a gastrointestinal surgery done to help obese patients achieve significant sustained weight loss. This may include, reducing the size of the stomach with a gastric band or through the removal of a portion of the stomach (sleeve gastrectomy or biliopancreatic diversion with duodenal switch) or by resecting and re-routing the small intestine to a small stomach pouch (gastric bypass surgery).
The Global Bariatric Surgery Devices Market was valued at $ XX Mn in 2018 and is forecast to grow at XX% CAGR between 2018 and 2026, resulting in 2026 global sales of $ XX. The rise in geriatric population and upsurge in a number of patients suffering from chronic disorders are expected to drive the market growth. According to the WHO data review of 2016, 1.9 billion people are overweight out of which 650 million suffer from obesity. Almost 13% of the population in the age range of 18 years and older are obese and 41 million children under the age of 5 years suffer from obesity. Growing inclination toward sedentary lifestyle and burgeoning frequency of consuming junk food are the most likely to boost obesity, and eventually the market for obesity surgery devices.
The Global Bariatric Surgery Devices Market is segmented on the basis of Type, Indication, End-user, and region.
Based on the Type: Minimally Invasive Surgical Devices, Non-Invasive Surgical Devices.
Based on the Procedure: Revision Bariatric Surgery, Sleeve Gastrectomy, Gastric Bypass, Non-Invasive Bariatric Surgery, Adjustable Gastric Banding, Biliopancreatic Diversion With Duodenal Switch, Mini-Gastric Bypass
Based on End-User: Hospital Pharmacies, Ambulatory Surgical Center, Bariatric Surgery Clinics
Based on Region: North America, Asia-Pacific, Europe, and LAMEA. North America is considered as the biggest market of Transdermal drug delivery systems. Moreover, the presence of main pharmaceutical organizations in these regions has decidedly affected the development of the market. Nations, for example, the US, Canada, Mexico, have represented a solid interest of idiopathic pulmonary fibrosis therapeutics credited to the expanding number of IPF rate happening in these nations.
The report covers in-depth analysis of the Global Bariatric Surgery Devices Market. The report assesses the market products pipeline by stage of development (early development, pre-clinical, clinical and In approval), By Type (Minimally Invasive Surgical Devices, Non-Invasive Surgical Devices). In addition, the report includes key insights on other development activities, including (but not limited to) – licensing (In and Out), collaborations, acquisitions, reimbursement, patent, and regulatory designations.
The report includes in-depth company profiles of key players in the Global Bariatric Surgery Devices Market. The company profile includes key information on the overview, financial highlights, product portfolio, business strategies, and key recent developments.
The report highlights information on emerging companies with potentially disruptive technologies and new market entrants.
Data Collation (Primary & Secondary)
In-house Estimation (Based on proprietary databases and Models)
Market-related information is assembled from both primary and secondary sources.
Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others.
Top-down and bottom-up approaches: The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.